Testing the premise that inhalation of antibiotics reduces the incidence of ventilator-associated pneumonia, French and Chinese investigators show clinical benefits of a 3-day course of
The importance of implementation of reliever-based regimens in adolescents and adults with asthma is emphasized in a commentary based on the Global Initiative for Asthma
An update of the 2019 the Canadian Thoracic Society (CTS) Guideline provides “recommendations from a comprehensive systematic review with a meta-analysis and expert-informed clinical remarks
A member of a new P2X3 antagonist class of antitussives for refractory or unexplained chronic cough, gefapixant 45 mg orally twice daily modestly improved cough
A guideline presents recommendations from a comprehensive systematic review with a meta-analysis and expert-informed clinical remarks to optimize maintenance pharmacologic therapy for individuals with stable
The P2X3 antagonist gefapixant 45 mg orally twice daily produced modest improvements in cough frequency, cough severity, and cough-specific quality of life in patients with
Using the case of a 66-year-old man with underlying chronic obstructive pulmonary disease (COPD) who presented to the emergency department with symptoms consistent with community-acquired
“Biologics can reduce the burden of asthma exacerbations and [oral corticosteroids (OCS)] use in patients with asthma,” write authors of a Commentary on achieving clinical
The use of the first generic maintenance inhaler approved for asthma and chronic obstructive pulmonary disease (COPD) produced outcomes similar to those with the original
In a phase 3 trial, dupilumab therapy improved outcomes in patients with COPD who had type 2 inflammation as indicated by elevated blood eosinophil counts.